Ignite Creation Date:
2024-05-06 @ 2:22 AM
Last Modification Date:
2024-10-26 @ 11:17 AM
Study NCT ID:
NCT02023359
Status:
COMPLETED
Last Update Posted:
2015-12-29
First Post:
2013-12-23
Brief Title:
Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor HR Positive Human Epidermal Growth Factor 2 HER2 - Metastatic Breast Cancer
Sponsor:
Novartis Healthcare AS
Organization:
Novartis
Organization Data
Organization:
Novartis
Class:
INDUSTRY
Study ID:
CRAD001JDK02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Novartis Healthcare AS
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None